544341 (1)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emcure Pharmaceuticals and Landmark Global Learning submitted clarifications to BSE Surveillance Department stating no undisclosed … | |||||||||||||||
Emcure Pharmaceuticals and Landmark Global Learning submitted clarifications to BSE Surveillance Department stating no undisclosed price-sensitive information exists behind recent significant volume/price movements in their scrips.
| |||||||||||||||